 | Up a level |
Asgharzadeh, Shahab 
ORCID: 0000-0002-0510-3848, Salo, Jill A., Ji, Lingyun, Oberthuer, Andre, Fischer, Matthias, Berthold, Frank, Hadjidaniel, Michael, Liu, Cathy Wei-Yao, Metelitsa, Leonid S., Pique-Regi, Roger ORCID: 0000-0002-1262-2275, Wakamatsu, Peter, Villablanca, Judith G., Kreissman, Susan G., Matthay, Katherine K., Shimada, Hiroyuki, London, Wendy B., Sposto, Richard and Seeger, Robert C.
(2012).
Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma.
J. Clin. Oncol., 30 (28).
S. 3525 - 3533.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Park, Julie R., Bagatell, Rochelle, Cohn, Susan L., Pearson, Andrew D., Villablanca, Judith G., Berthold, Frank, Burchill, Susan, Boubaker, Ariane, McHugh, Kieran, Nuchtern, Jed G., London, Wendy B., Seibel, Nita L., Lindwasser, O. Wolf, Maris, John M., Brock, Penelope, Schleiermacher, Gudrun, Ladenstein, Ruth, Matthay, Katherine K. and Valteau-Couanet, Dominique (2017). Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting. J. Clin. Oncol., 35 (22). S. 2580 - 2593. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Park, Julie R., Villablanca, Judith G., Hero, Barbara, Kushner, Brian H., Wheatley, Keith, Beiske, Klaus H., Ladenstein, Ruth L., Baruchel, Sylvain, Macy, Margaret E., Moreno, Lucas, Seibel, Nita L., Pearson, Andrew D., Matthay, Katherine K. and Valteau-Couanet, Dominique (2022). Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting. Cancer, 128 (21). S. 3775 - 3784. HOBOKEN: WILEY. ISSN 1097-0142